Abstract
Translational bioinformatics plays a crucial role in biomarker discovery as it helps to bridge the gap between bench research and bedside clinical applications. Thanks to newer and faster molecular profiling technologies and decreasing costs, there are many opportunities for researchers to explore the molecular and physiological mechanisms of diseases. Biomarker discovery, or the identification of observable indicators of underlying biological state, enables researchers to characterize patients better, predict treatment responses and monitor disease outcomes. In addition, biomarker tests specialized for a disease can enable early detection and intervention or prevention.
Due to increasing prevalence and rising treatment costs, mental health disorders have become an important area for biomarker discovery and for improved patient treatment and care. Exploration of underlying biological mechanisms is key to the understanding of pathogenesis and pathophysiology of mental disorders.
In this chapter, we cover various data types commonly used in bioinformatics, file formats, and common methods for acquisition of such data. We also address the strengths and limitations of the different types of data used in biomarker discovery. We cover data and knowledge related to molecular and cellular phenomena, and their relationships to other phenomena in mental health. Finally, we address methods to transform molecular and cellular data into meaningful information about higher level human function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
EMBL-EBI. What is bioinformatics ? May 21 2020; Available from: https://www.ebi.ac.uk/training/online/course/bioinformatics-terrified/what-bioinformatics-0.
TowardsDataScience. What is bioinformatics. 2017; Available from: https://towardsdatascience.com/what-is-bioinformatics-703170763999
Biospace. Careers in bioinformatics: hot and getting hotter. 2019. May 21 2020; Available from: https://www.biospace.com/article/careers-in-bioinformatics-hot-and-getting-hotter.
Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010;5(6):463–6.
Tenenbaum JD, et al. Translational bioinformatics in mental health: open access data sources and computational biomarker discovery. Brief Bioinform. 2019;20(3):842–56.
Rush AJ, Ibrahim HM. A Clinician’s perspective on biomarkers. Focus (Am Psychiatr Publ). 2018;16(2):124–34.
evariant.com. What is healthcare big data? 2019. Dec 23 2019; Available from: https://www.evariant.com/faq/what-is-healthcare-big-data.
PRNewswire. $11.45 bn big data in healthcare market, 2025. 2018 Dec 23 2019; Available from:https://www.prnewswire.com/news-releases/1145-bn-big-data-in-healthcare-market-2025-300623544.html.
Channels IE. How data analytics helps mental health issues. Dec 23 2019; Available from:https://channels.theinnovationenterprise.com/articles/how-social-media-analysis-can-improve-mental-health.
Wikipedia. Bioinformatics. Dec 23 2019; Available from: https://en.wikipedia.org/wiki/Bioinformatics.
NLM. What is the precision medicine initiative? Dec 24 2019; Available from: https://ghr.nlm.nih.gov/primer/precisionmedicine/initiative.
Wikipedia. Biomarker. Dec 24 2019; Available from: https://en.wikipedia.org/wiki/Biomarker.
Lin Y, et al. Computer-aided biomarker discovery for precision medicine: data resources, models and applications. Brief Bioinform. 2019;20(3):952–75.
Cook I. Biomarkers in psychiatry: potentials, pitfalls, and pragmatics. Primary Psychiatry. 2008;15(3):54–9.
Sokolowska I, et al. The potential of biomarkers in psychiatry: focus on proteomics. J Neural Transm (Vienna). 2015;122(Suppl 1):S9–18.
Herron JW, Nerurkar L, Cavanagh J. Neuroimmune Biomarkers in Mental Illness. Curr Top Behav Neurosci. 2018;40:45–78.
Harris KM, Schorpp KM. Integrating biomarkers in social stratification and Health Research. Annu Rev Sociol. 2018;44:361–86.
Biologically-inspired biomarkers for mental disorders. EBioMedicine. 2017;17:1–2.
Payne PRO, Embi, PJ, Translational informatics: realizing the promise of knowledge-driven healthcare. 2014.
NHGRI. Genomics and medicine. 2019. April 27, 2020; Available from: https://www.genome.gov/health/Genomics-and-Medicine.
NHGRI. The cost of sequencing a human genome. Feb 7 2020; Available from: https://www.genome.gov/about-genomics/fact-sheets/Sequencing-Human-Genome-cost.
Wikipedia. $1,000 genome. Sep 14 2020; Available from: https://en.wikipedia.org/wiki/$1,000_genome.
Alexander Arguello P, et al. From genetics to biology: advancing mental health research in the genomics ERA. Mol Psychiatry. 2019;24(11):1576–82.
ScienceDaily. Largest study of its kind reveals that many psychiatric disorders arise from common genes. 2019. May 21 2020; Available from: https://www.sciencedaily.com/releases/2019/12/191212142634.htm.
Cross-Disorder Group of the Psychiatric Genomics Consortium. Electronic address, p.m.h.e. and C. Cross-disorder Group of the Psychiatric Genomics. Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders. Cell. 2019;179(7):1469–82. e11
Sabatello M. Psychiatric genomics and public mental health in the young mind. Am J Bioeth. 2017;17(4):27–9.
Gandal MJ, et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science. 2018;359(6376):693–7.
Pantazatos SP, et al. Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity. Mol Psychiatry. 2017;22(5):760–73.
NLM. Gene. April 27, 2020; Available from: https://ghr.nlm.nih.gov/primer/basics/gene.
Wikipedia. Gene. April 27 2020; Available from: https://en.wikipedia.org/wiki/Gene.
NLM. Can genes be turned on and off in cells? April 27 2020; Available from: https://ghr.nlm.nih.gov/primer/howgeneswork/geneonoff.
Wang W, Wang GZ. Understanding molecular mechanisms of the brain through transcriptomics. Front Physiol. 2019;10:214.
Kathuria A, et al. Transcriptome analysis and functional characterization of cerebral organoids in bipolar disorder. Genome Med. 2020;12(1):34.
Zhou Y, et al. Interactome analysis reveals ZNF804A, a schizophrenia risk gene, as a novel component of protein translational machinery critical for embryonic neurodevelopment. Mol Psychiatry. 2018;23(4):952–62.
Park DI, Turck CW. Interactome studies of psychiatric disorders. Adv Exp Med Biol. 2019;1118:163–73.
Xiao Y, et al. The DNA methylome and transcriptome of different brain regions in schizophrenia and bipolar disorder. PLoS One. 2014;9(4):e95875.
Kohen R, et al. Transcriptome profiling of human hippocampus dentate gyrus granule cells in mental illness. Transl Psychiatry. 2014;4:e366.
Wang X, Cairns MJ. Understanding complex transcriptome dynamics in schizophrenia and other neurological diseases using RNA sequencing. Int Rev Neurobiol. 2014;116:127–52.
ENCODE. ENCODE: Deciphering function in the human genome. Sep 16 2020; Available from: https://www.genome.gov/27551473/genome-advance-of-the-month-encode-deciphering-function-in-the-human-genome#.
NLM. Protein. April 27 2020; Available from: https://ghr.nlm.nih.gov/primer/howgeneswork/protein.
Wikipedia. Reverse phase protein lysate microarray. April 27 2020; Available from: https://en.wikipedia.org/wiki/Reverse_phase_protein_lysate_microarray.
Bot M, et al. Serum proteomic profiling of major depressive disorder. Transl Psychiatry. 2015;5:e599.
Lista S, et al. Evolving relevance of Neuroproteomics in Alzheimer’s disease. Methods Mol Biol. 2017;1598:101–15.
Brinkmalm A, et al. Explorative and targeted neuroproteomics in Alzheimer’s disease. Biochim Biophys Acta. 2015;1854(7):769–78.
Liao L, et al. Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J Biol Chem. 2004;279(35):37061–8.
Metabolon. About metabolomics. April 27 2020; Available from: https://www.metabolon.com/what-we-do/about-metabolomics.
EMBL-EBI. Small molecules. Jan 8 2020; Available from: https://www.ebi.ac.uk/training/online/course/introduction-metabolomics/what-metabolomics/no-glossary-small-molecules-no-glossary.
Roberts LD, et al., Targeted metabolomics. Curr Protoc Mol Biol, 2012. Chapter 30: Unitas 30.2.1–24.
Shah SH, Kraus WE, Newgard CB. Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation. 2012;126(9):1110–20.
Emwas AH, et al. NMR spectroscopy for metabolomics research. Metabolites. 2019;9(7):123.
MayoClinic. Targeted metabolomics. 2020. Aug 18 2020; Available from: https://www.mayo.edu/research/core-resources/metabolomics-core/services/targeted-metabolomics.
Mapstone M, et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat Med. 2014;20(4):415–8.
Martins-de-Souza D, et al. Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients. Transl Psychiatry. 2012;2:e87.
Kahl KG, Stapel B, Frieling H. Link between depression and cardiovascular diseases due to epigenomics and proteomics: focus on energy metabolism. Prog Neuro-Psychopharmacol Biol Psychiatry. 2019;89:146–57.
Humer E, Probst T, Pieh C. Metabolomics in psychiatric disorders: What we learn from animal models. Meta. 2020;10(2):72.
NLM. Epigenome. April 27 2020; Available from: https://ghr.nlm.nih.gov/primer/howgeneswork/epigenome.
Teng M, Irizarry RA. Accounting for GC-content bias reduces systematic errors and batch effects in ChIP-seq data. Genome Res. 2017;27(11):1930–8.
Wikipedia. ChIP sequencing. 2020. May 21 2020; Available from: https://en.wikipedia.org/wiki/ChIP_sequencing.
ScienceDirect. ChIP-sequencing. 2013. May 21, 2020; Available from: https://www.sciencedirect.com/topics/neuroscience/chip-sequencing.
Nature. Transcription factor. 2014. May 21 2020; Available from: https://www.nature.com/scitable/definition/transcription-factor-167/.
Park PJ. ChIP-seq: advantages and challenges of a maturing technology. Nat Rev Genet. 2009;10(10):669–80.
Kular L, Kular S. Epigenetics applied to psychiatry: clinical opportunities and future challenges. Psychiatry Clin Neurosci. 2018;72(4):195–211.
Palma-Gudiel H, Fananas L. An integrative review of methylation at the serotonin transporter gene and its dialogue with environmental risk factors, psychopathology and 5-HTTLPR. Neurosci Biobehav Rev. 2017;72:190–209.
Nievergelt CM, et al. Genomic approaches to posttraumatic stress disorder: the psychiatric genomic consortium initiative. Biol Psychiatry. 2018;83(10):831–9.
Kumsta R. The role of epigenetics for understanding mental health difficulties and its implications for psychotherapy research. Psychol Psychother. 2019;92(2):190–207.
Augustin R, et al. Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10. BMC Med Genet. 2012;13:35.
Elsivier. Pathway studio. Sep 16 2020; Available from: https://www.elsevier.com/solutions/pathway-studio-biological-research.
Issler O, Chen A. Determining the role of microRNAs in psychiatric disorders. Nat Rev Neurosci. 2015;16(4):201–12.
Narahari A, Hussain M, Sreeram V. MicroRNAs as biomarkers for psychiatric conditions: a review of current research. Innov Clin Neurosci. 2017;14(1–2):53–5.
Allen L, Dwivedi Y. MicroRNA mediators of early life stress vulnerability to depression and suicidal behavior. Mol Psychiatry. 2020;25(2):308–20.
van den Berg MMJ, et al. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Prog Neurobiol. 2020;185:101732.
Roser AE, et al. Circulating miRNAs as diagnostic biomarkers for Parkinson’s disease. Front Neurosci. 2018;12:625.
Wang X, Gardiner EJ, Cairns MJ. Optimal consistency in microRNA expression analysis using reference-gene-based normalization. Mol BioSyst. 2015;11(5):1235–40.
Beveridge NJ, Cairns MJ. MicroRNA dysregulation in schizophrenia. Neurobiol Dis. 2012;46(2):263–71.
Wang J, et al. microRNAs as novel biomarkers of schizophrenia (review). Exp Ther Med. 2014;8(6):1671–6.
Song L, et al. CINdex: a Bioconductor package for analysis of chromosome instability in DNA copy number data. Cancer Inform. 2017;16:1176935117746637.
Cuccaro D, et al. Copy number variants in Alzheimer’s disease. J Alzheimers Dis. 2017;55(1):37–52.
Nothen MM, et al. New findings in the genetics of major psychoses. Dialogues Clin Neurosci. 2010;12(1):85–93.
Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148(6):1223–41.
Wikipedia. Image segmentation. 2020. May 21 2020; Available from: https://en.wikipedia.org/wiki/Image_segmentation.
Wikipedia. Medical imaging. 2020. May 21 2020; Available from: https://en.wikipedia.org/wiki/Medical_imaging.
Davatzikos C, et al. Cancer imaging phenomics toolkit: quantitative imaging analytics for precision diagnostics and predictive modeling of clinical outcome. J Med Imaging (Bellingham). 2018;5(1):011018.
Wolf I, et al. The medical imaging interaction toolkit. Med Image Anal. 2005;9(6):594–604.
Shen D, Wu G, Suk HI. Deep learning in medical image analysis. Annu Rev Biomed Eng. 2017;19:221–48.
Jiang W, King TZ, Turner JA. Imaging genetics towards a refined diagnosis of schizophrenia. Front Psych. 2019;10:494.
Whitfield-Gabrieli S, et al. Brain connectomics predict response to treatment in social anxiety disorder. Mol Psychiatry. 2016;21(5):680–5.
Okano K, et al. Real-time fMRI feedback impacts brain activation, results in auditory hallucinations reduction: part 1: superior temporal gyrus -preliminary evidence. Psychiatry Res. 2020;286:112862.
Wikiversity. Microbiome and mental health. Jan 14 2020; Available from: https://en.wikiversity.org/wiki/Microbiome_and_Mental_Health.
Bastiaanssen TFS, et al. Gutted! Unraveling the role of the microbiome in major depressive disorder. Harv Rev Psychiatry. 2020;28(1):26–39.
Skonieczna-Zydecka K, et al. Microbiome-the missing link in the gut-brain axis: Focus on its role in gastrointestinal and mental health. J Clin Med. 2018;7(12):521.
Rottig S, Rujescu D. Microbiome in psychiatry: where will we go? Eur Arch Psychiatry Clin Neurosci. 2018;268(1):1–2.
Cryan JF. Stress and the microbiota-gut-brain Axis: an evolving concept in psychiatry. Can J Psychiatr. 2016;61(4):201–3.
Licinio J, Wong ML. The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry. 1999;4(4):317–27.
Wong ML, et al. Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Mol Psychiatry. 2016;21(6):797–805.
Ashburner M, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25(1):25–9.
EBI. Gene set enrichment analysis and pathway analysis. 2020 May 21 2020; Available from: https://www.ebi.ac.uk/training/online/course/functional-genomics-ii-common-technologies-and-data-analysis-methods/gene-set-enrichment.
EBI. Gene ontology. 2020 May 21 2020; Available from: https://www.ebi.ac.uk/training/online/glossary/gene-ontology.
NIH. Systems biology as defined by NIH. April 27 2020; Available from: https://irp.nih.gov/catalyst/v19i6/systems-biology-as-defined-by-nih.
ISB. What is systems biology? April 27, 2020; Available from: https://isbscience.org/about/what-is-systems-biology/.
Harvard. Welcome to the department of systems biology. April 27 2020; Available from: https://sysbio.med.harvard.edu/.
Kitano H. Systems biology: a brief overview. Science. 2002;295(5560):1662–4.
Wikipedia. Systems biology. April 27 2020; Available from: https://en.wikipedia.org/wiki/Systems_biology.
Gutierrez Najera NA, Resendis-Antonio O, Nicolini H. “Gestaltomics”: Systems biology schemes for the study of neuropsychiatric diseases. Front Physiol. 2017;8:286.
NBTS. Tumor types: Understanding brain tumors. Sep 16 2020; Available from: https://braintumor.org/brain-tumor-information/understanding-brain-tumors/tumor-types/.
Behnan J, Finocchiaro G, Hanna G. The landscape of the mesenchymal signature in brain tumours. Brain. 2019;142(4):847–66.
Verhaak RG, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98–110.
van den Bent MJ. Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective. Acta Neuropathol. 2010;120(3):297–304.
Louis DN, et al. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–20.
DeWeerdt S. The genomics of brain cancer. Nature. 2018;561(7724):S54–5.
APA. What is Alzheimer’s disease? Dec 28 2019]; Available from: https://www.psychiatry.org/patients-families/alzheimers/what-is-alzheimers-disease.
Di Resta C, Ferrari M. New molecular approaches to Alzheimer’s disease. Clin Biochem. 2019;72:81–6.
NIA. Alzheimer’s disease genetics fact sheet. Dec 31 2019; Available from: https://www.nia.nih.gov/health/alzheimers-disease-genetics-fact-sheet.
Verheijen J, Sleegers K. Understanding Alzheimer disease at the Interface between genetics and transcriptomics. Trends Genet. 2018;34(6):434–47.
NIA. What happens to the brain in Alzheimer’s disease? Aug 18, 2020; Available from: https://www.nia.nih.gov/health/what-happens-brain-alzheimers-disease.
Huang CC, et al. The combination of functional and structural MRI is a potential screening tool in Alzheimer’s disease. Front Aging Neurosci. 2018;10:251.
Jones KA, Menniti FS, Sivarao DV. Translational psychiatry--light at the end of the tunnel. Ann N Y Acad Sci. 2015;1344:1–11.
NIMH. Towards a genomic psychiatry: Recommendations of the genomics workgroup of the NAMHC. 2018. May 21 2020. Available from: https://www.nimh.nih.gov/about/director/messages/2018/towards-a-genomic-psychiatry-recommendations-of-the-genomics-workgroup-of-the-namhc.shtml.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bhuvaneshwar, K., Gusev, Y. (2021). Bioinformatics in Mental Health: Deriving Knowledge from Molecular and Cellular Data. In: Tenenbaum, J.D., Ranallo, P.A. (eds) Mental Health Informatics. Health Informatics. Springer, Cham. https://doi.org/10.1007/978-3-030-70558-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-70558-9_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-70557-2
Online ISBN: 978-3-030-70558-9
eBook Packages: MedicineMedicine (R0)